-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Anika Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2010 to 2024.
- Anika Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending December 31, 2024 was 14.7M shares, a 0.44% increase year-over-year.
- Anika Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 14.7M shares, a 0.44% increase from 2023.
- Anika Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 14.7M shares, a 0.89% decline from 2022.
- Anika Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 14.8M shares, a 1.05% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)